Elligo's PatientSelect® Model vs. Traditional Enrollment

The conventional method for enrolling participants in clinical trials relies on sites to identify patients, resulting in an inefficient model that hampers trial startup times. Elligo's PatientSelect® model, however, provides direct access to a diverse pool of previously untapped patients through HIPAA-compliant identified healthcare data, healthcare-integrated sites, proprietary technology, and AI-powered analytics. This approach eliminates recruitment costs, mitigates enrollment challenges, and places a strong emphasis on meeting the needs of the patients.

As a leading healthcare-enabling research organization, Elligo excels at optimizing the convergence of healthcare and research. Our commitment involves preserving the integrity of the trusted patient-physician relationship and leveraging electronic health records to expedite the development of new pharmaceuticals, biotechnology, medical devices, and diagnostic products. In doing so, we extend the option of clinical research as a care alternative to a broader spectrum of patients.